The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Sorry Pete, why would this level be a ceiling? I don’t understand.
I note the merger will take place at £1.29 per share.
That’s going to be the new base I imagine until the merger, then it’s pure upside from here as the Nasdaq listing becomes effective and we rocket.
Praying this one is a belter!
Ok, fingers crossed it’s nothing then. It’s the first company I’ve been invested in that is subject to a merger of this nature via a SPAC, hence my initial concern!
Looking forward to further updates soon from 4D.
https://www.rigrodskylong.com/cases-longevity-acquisition-corporation
What’s all this about guys? $LOAC under investigation.
Because many trades are never accurately reported....
Given the wording in the merger RNS in relation to the cash available post-merger, I would hope that this wouldn’t be required. That said, I don’t know of course.
Potentially a good sign that new recruits are being sought, including a senior scientist: https://www.4dpharmaplc.com/en/contact/join-us
@starjump “ On the plus side, LOAC is above 4D's value currently.”
Well it would be, given that they are the SPAC and therefore a totally different entity. I don’t note any correlation (yet) between the two sp’s.
@ £20 a share I may topslice some profits ;)
Let’s hope for the best! Big year ahead for DDDD.
Pretty sad that all some people have to do is argue with others and spend their days trying to convince others they are right and know the outcome of this drill. This board is such a tedious read I’ll be glad once we finally have some proper news instead of all this regurgitated drivel and bickering.
Was looking back over recent RNS announcements and note that we are due an update of the sale of certain assets by 31/12/20.
The sums involved look pretty minor on the whole? Am I right in thinking we haven’t heard anything yet?
https://www.lse.co.uk/rns/ZOE/update-on-sale-of-dtu-and-kansas-nitrogen-assets-bc9qng720y778qe.html
$LOAC up almost 5% pre-market across the pond.
@terrier
Nice one, wish I’d known about this share sooner! My average is a shade above 90p, so looking pretty healthy at present.
@terrier
You know there’s merger news imminent in January which will see us listed on the Nasdaq?
77p is my guesstimate.
Good luck all, it’s certainly quiet in here today.
@hants
“ In October 2020 4D Pharma announced its intention to merge with Longevity Acquisition Corporation (NASDAQ: LOAC), a special purpose acquisition company (SPAC), and seek a NASDAQ listing. The merger is expected to be completed and the NASDAQ listing of 4D Pharma American Depositary Shares (ADSs) under the ticker symbol 'LBPS' is currently expected to become effective in early 2021, subject to approval of 4D shareholders and Longevity shareholders, and the SEC review process.”
50% rise here tomorrow would be nice!
Seems the US are waking up to what’s on the table here, hugely encouraging signs.
Up 30% at present! $LOAC
Can they see any black stuff yet....?!